SLPI
Antileukoproteinase
Also known as: ALK1, ALP, BLPI, HUSI, HUSI-I, SLPI_HUMAN, WAP4, WFDC4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P03973
- Gene
- SLPI
- Ensembl
- ENSG00000124107
- Chromosome
- 20
- Canonical length
- 132 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a secreted inhibitor which protects epithelial tissues from serine proteases. It is found in various secretions including seminal plasma, cervical mucus, and bronchial secretions, and has affinity for trypsin, leukocyte elastase, and cathepsin G. Its inhibitory effect contributes to the immune response by protecting epithelial surfaces from attack by endogenous proteolytic enzymes. This antimicrobial protein has antibacterial, antifungal and antiviral activity. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
132 residues, UniProt reviewed canonical sequence.
>P03973|SLPI
1 MKSSGLFPFL VLLALGTLAP WAVEGSGKSF KAGVCPPKKS AQCLRYKKPE CQSDWQCPGK
61 KRCCPDTCGI KCLDPVDTPN PTRRKPGKCP VTYGQCLMLN PPNFCEMDGQ CKRDLKCCMG
121 MCGKSCVSPV KALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLPI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 26,260 nTPM
Expression across tissuesHPA
Tissue
- cervix: 26,260 nTPM
- salivary gland: 14,072 nTPM
- seminal vesicle: 2,779 nTPM
- esophagus: 1,355 nTPM
- lung: 1,112 nTPM
- vagina: 687 nTPM
Single-cell type
- submucosal glandular cells: 31,818 nCPM
- respiratory secretory cells: 25,615 nCPM
- esophageal apical cells: 20,422 nCPM
- endometrial secretory cells: 16,782 nCPM
- conjunctival goblet cells: 12,809 nCPM
- respiratory deuterosomal cells: 12,518 nCPM
Immune cell
- neutrophil: 324 nTPM
- total PBMC: 7.9 nTPM
- non-classical monocyte: 4 nTPM
- basophil: 3.6 nTPM
- intermediate monocyte: 3.3 nTPM
- classical monocyte: 0.9 nTPM
Brain region
- choroid plexus: 50 nTPM
- thalamus: 14 nTPM
- cerebral cortex: 4.8 nTPM
- medulla oblongata: 4.1 nTPM
- midbrain: 4 nTPM
- pons: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLPI.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 27 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial humoral response
- immune response
- innate immune response
- negative regulation of protein binding
- negative regulation of viral genome replication
- response to lipopolysaccharide
- host-mediated perturbation of symbiont process
Molecular functions
- DNA binding
- endopeptidase inhibitor activity
- enzyme binding
- mRNA binding
- serine-type endopeptidase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLPI in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLPI as an antibody target. Whether an autoantibody or antibody against SLPI could matter depends on whether native SLPI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLPI is annotated as secreted, so native SLPI circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SLPI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...